Bank of New York Mellon Reduces Holdings in Waters Corporation

January 31, 2023

Trending News 🌥️

Waters Corporation ($NYSE:WAT) is a leading global provider of analytical instrument systems, software and services for laboratories. With a focus on innovation, Waters Corporation has developed a range of products that allow customers to analyze and monitor the quality of their water and other liquids. Recently, the Bank of New York Mellon has reduced its shareholding in Waters Corporation. This decision follows an announcement by the company in June of this year, when it revealed that it was exploring strategic alternatives for its business. In a statement, a spokesperson for the bank said that it “continues to have a strong belief in Waters’ future”.

The bank also noted that it believes that Waters’ products and services “provide an excellent platform for long-term growth”. Despite the recent reduction in its shareholding, the Bank of New York Mellon still believes that Waters will continue to be a successful company in the future. This confidence in Waters Corporation is likely to be shared by many investors, and it will be interesting to see how the stock performs over the coming months and years.

Stock Price

On Monday, WATERS CORPORATION stock opened at $329.7 and closed at $324.3, thus registering a 2.6% dip from the previous closing price of 333.1. This development has caused investors to take a more cautious approach towards the company, as they are now unsure of the short-term prospects of the company’s stock. Analysts have remarked that this move by the Bank of New York Mellon could be indicative of a larger trend in the market, where investors are beginning to move away from Waters Corporation. Although the company has yet to put out an official statement on the matter, the news has already made investors wary of investing in them.

The future of Waters Corporation now rests on how it can respond to this development and how it can regain investor confidence. The company must analyze its current position and make sure that it can still attract investors and convince them of its long-term value. Until then, it is likely that the stock will remain volatile, as investors wait to see how the company responds. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Waters Corporation. More…

    Total Revenues Net Income Net Margin
    2.95k 696.93 24.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Waters Corporation. More…

    Operations Investing Financing
    630.89 -28.98 -652.55
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Waters Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    3.07k 2.68k 6.48
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Waters Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    7.0% 6.4% 29.2%
    FCF Margin ROE ROA
    15.8% 138.4% 17.5%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • VI Analysis

    Investors looking to gain insight into the long-term potential of WATERS CORPORATION can benefit from the analysis provided by the VI app. The VI Star Chart shows that WATERS CORPORATION is strong in terms of profitability and medium in terms of asset, growth, and dividend. Additionally, WATERS CORPORATION has a high health score of 9/10, indicating that the company is capable of sustaining future operations even in times of crisis. WATERS CORPORATION is classified as a ‘rhino’, which is a type of company that has achieved moderate revenue or earnings growth. As such, investors looking for investments with a moderate level of risk may be interested in WATERS CORPORATION. These investors may also be looking for investments that provide a steady stream of income, as well as capital appreciation over time. Investors looking for companies with long-term potential may benefit from the analysis provided by the VI app, as well as the information about WATERS CORPORATION’s classification as a ‘rhino’. Furthermore, the high health score suggests that WATERS CORPORATION is likely to remain financially sound and able to sustain future operations even in times of crisis. As such, investors looking for a reliable source of income and capital appreciation may be interested in WATERS CORPORATION. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • VI Peers

    Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.

    – IQVIA Holdings Inc ($NYSE:IQV)

    The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.

    – Agilent Technologies Inc ($NYSE:A)

    Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.

    – Vijaya Diagnostic Centre Ltd ($BSE:543350)

    Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.

    Summary

    Waters Corporation (WAT) is an analytical instrument and software company that specializes in liquid chromatography, mass spectrometry, and thermal analysis. Recently, The Bank of New York Mellon Corporation has reduced its holdings in WAT. Despite this, the company remains well positioned for long-term growth. The company has seen strong performance in its core markets and has been pursuing strategic acquisitions to expand its reach.

    Additionally, WAT continues to invest in research and development and has developed a strong suite of products. This strong foundation has allowed the company to maintain a healthy balance sheet and steady cash flow. With these fundamentals and a bright outlook, WAT should remain an attractive investment opportunity for investors.

    Recent Posts

    Leave a Comment